Tag: Islatravir

Islatravir is a potent, investigational antiretroviral drug developed by Merck for the treatment of HIV. Its unique mechanism of action places it in a new class of HIV medications known as the nucleoside reverse transcriptase translocation inhibitors (NRTTIs).

With lifelong antiretroviral therapy, the life expectancy for people living with HIV now approaches that of the general population. A key question in ongoing research is, **what type of drug is Islatravir?** It is a first-in-class nucleoside reverse transcriptase translocation inhibitor (NRTTI).